Daniel C. Pevear, PhD

Founder and Senior Vice President of Biology and Grants Development
Venatorx Pharmaceuticals

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-1241) Cefepime Pharmacodynamics Against Pseudomonas aeruginosa Evaluated in a Chemostat Infection Model: Do Generalized Cephalosporin Targets Translate?
  Friday, October 18, 2024

  12:15 PM - 1:30 PM US PT